Back to search

Article

SABR-Dual: A phase II/III trial of two-fraction versus five-fraction stereotactic radiotherapy for localized low- and favorable intermediate-risk prostate cancer

2023-08-03

Abstract excerpt

<h4>Background: </h4> Dose-escalated radiotherapy is known to improve progression free survival in patients with localized prostate cancer, and recent advances have led to the standardization of ultrahypofractionated stereotactic ablative radiotherapy (SABR) delivered in just 5-fractions. Based on the known effectiveness of the accepted though invasive 2-fraction treatment method of high-dose-rate brachytherapy an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7d229c6c-d7aa-5588-bb81-7f079cb21384
DOI
10.21203/rs.3.rs-3145183/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SABR-Dual: A phase II/III trial of two-fraction versus five-fraction stereotactic radiotherapy for localized low- and favorable intermediate-risk prostate cancerDOI 10.21203/rs.3.rs-3145183/v1
Quality of Life After Definitive Linear Accelerator-Based Stereotactic Radiotherapy for Prostate Cancer: A Longitudinal StudySemantic proximity
Current State of Adjuvant Hormone Therapy in Prostate Cancer and in the Management of Pelvic Nodal Recurrence: A Narrative ReviewSemantic proximity
Stereotactic body radiation therapy is beneficial for a subgroup of patients with urothelial cancer and solitary metastatic disease: a single institution real-world experienceSemantic proximity
Focal Therapy Using High-Intensity Focused Ultrasound for Low- and Intermediate-Risk Prostate Cancer: Results from a Prospective, Multicenter TrialSemantic proximity
Radiotherapy Approaches for High-Risk Prostate Cancer with Elective Lymph Node Fields: A Comparative AnalysisSemantic proximity
Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cellsSemantic proximity
Effectiveness of new treatment modalities for localized prostate cancer through patient-reported outcome measures: 5 years comparative study.Semantic proximity
Dosiomics-based prediction of late genitourinary toxicity after Cyberknife for prostate cancer: a SHAP-explainable machine learning approachSemantic proximity
Results of ATOMS (Adjustable Trans-Obturator Male System) in Patients with Prostate Cancer treated with Prostatectomy and Radiotherapy: A Multicenter StudySemantic proximity
The Role of Whole-Gland and Focal Cryotherapy in Recurrent Prostate CancerSemantic proximity
Model-Based Comparison of Fractionation Regimens for Stereotactic Partial Breast Irradiation Using Uncomplicated Tumor Control Probability and Excess Absolute RiskSemantic proximity
Salvage stereotactic body radiation therapy for locally recurrent prostate cancer following primary radiation therapy, are benefits worth toxicity risk?: A systematic reviewSemantic proximity
Select a neighboring publication to make it the new centre.